Quantum computing has been lurking in the background for years. Discover 5 cutting-edge science sectors like CRISPR and ...

In contrast, CRISPR’s product candidates are aimed at being a one-time and done treatment, tackling the root of the problem (see image below ... I/we have no stock, option or similar derivative ...

The iStock Unlimited AI monthly subscription plan grants you access to our AI –powered tools to generate new AI images and to modify images (your generated images or stock images ... access to the ...

CRISPR Therapeutics is still losing money, but it also finished March with $1.9 billion in cash after burning through $134 ...

Shares of CRISPR Therapeutics have lost 15.8% so far this year compared with the industry’s decline of 2.3%. Zacks Investment Research Image Source: Zacks Investment Research CRISPR Therapeutics ...

The only gene-editing therapy currently on the market is a CRISPR–Cas9-based treatment for two blood disorders, sickle-cell ...

One of them is CRISPR Therapeutics ( CRSP 1.99%). It has an approved gene-editing therapy, but investors haven't been buying ...

KJ received the bespoke CRISPR treatment 6.5 months after birth, receiving three infusions of the therapy as of April 2025.

Researchers at UC Berkeley’s Innovative Genomics Institute, or IGI, developed a revolutionary treatment using CRISPR gene ...

Globally, people get animal protein mostly from chickens, with pigs and cattle in second and third place. A 2023 report estimated that pigs account for 34% of all meat that’s eaten. Of the billion ...

The investment in AMD marks a continuation of ARK’s recent accumulation of the stock, indicating a strategic position in the chipmaker. Another significant investment was made in CRISPR ...